All Sightglass Articles
-
3.9KClinicalExperiencing SightGlass Vision’s Spectacle Lenses
December 15, 2021 By Joe Rappon, OD, MS, FAAO, and Kylvin Ho, OD, FIAOMC As children continue to develop myopia at earlier...
-
2.3KLatest Myopia NewsCooperVision Announces Results from Two-Year SightGlass Clinical Trial
October 7, 2021 SAN RAMON, Calif. — CooperVision announced the results from its two-year clinical trial on the SightGlass Diffusion Optics Technology§...
-
2.9KIn The PipelineOIS Hosts Virtual Myopia Innovation Showcase
April 30, 2021 The Ophthalmology Innovation Summit (OIS) hosted a virtual Myopia Innovation Showcase on Thursday, April 29. The session started with...
-
6.6KSpectaclesWhat’s New in Spectacle Lenses for Myopia Management?
January 1, 2021 By Krupa Philip, PhD, Brien Holden Vision Institute Although 2020 is a year that many will consider as best...
-
5.6KClinicalInvestigational and Early-stage Myopia Interventions – A Farsighted View
November 1, 2020 By Thomas Aller, OD, FBCLA Collaborator, BHVI With the increasing incidence of myopia all around the world, predictions of...
-
3.5KIn The PipelineSightglass Vision Reports 12-month Results for its CYPRESS Study
October 9, 2020 An ongoing CYPRESS study of Sightglass Vision’s novel eyeglasses designed to slow progression of myopia in children “demonstrated the...
-
24.4KClinicalNovel DOT Lenses from SightGlass Vision Show Great Promise to Fight Myopia
April 21, 2020 By Joe Rappon, OD, MS, FAAO Jay Neitz, PhD Maureen Neitz, PhD Spectacles have been the mainstay modality for...
-
3.6KIn The PipelineSightGlass Presents CYPRESS Study Baseline Data at International Myopia Conference
CYPRESS is a multi-center, double-masked, randomized controlled pivotal clinical study.